Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease

被引:522
|
作者
Barquera, Simon [1 ]
Pedroza-Tobias, Andrea [1 ]
Medina, Catalina [1 ]
Hernandez-Barrera, Lucia [1 ]
Bibbins-Domingo, Kirsten [2 ]
Lozano, Rafael [1 ]
Moran, Andrew E. [3 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico
[2] Univ Calif San Francisco, Div Gen Med, San Francisco, CA 94143 USA
[3] Columbia Univ, Presbyterian Hosp, Div Gen Med, New York, NY USA
关键词
Ischemic heart disease; Cerebrovascular disease; DALYs; Epiderniologic transition; CORONARY-HEART-DISEASE; SODIUM CONSUMPTION PROJECTIONS; SUGAR-SWEETENED BEVERAGES; POPULATION-WIDE REDUCTION; NUTRITION TRANSITION; PHYSICAL-ACTIVITY; PUBLIC-HEALTH; ALCOHOL-CONSUMPTION; MORTALITY BENEFITS; PRIMARY PREVENTION;
D O I
10.1016/j.arcmed.2015.06.006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Atherosclerotic cardiovascular disease (ACD) is the leading cause of mortality worldwide. The objective of this paper is to provide an overview of the global burden of ACD and its risk factors and to discuss the main challenges and opportunities for prevention. Publicly available data from the Global Burden of Disease Study were analyzed for ischemic heart disease (IHD), ischemic stroke and ACD risk factors. Data from the WHO Global Health Observatory were used to describe prevalence of diverse cardiometabolic risk factors. World Bank Gross Domestic Product per capita (GDPc) information was used to categorize countries according to income level. Cardiovascular mortality decreased globally from 1990-2010 with important differences by GDPc; during 1990 there was a positive association between IHD mortality and GDPc. Higher-income countries had higher rates compared to those of lower-income countries. High levels of body mass index (BMI), blood pressure, glucose and cholesterol have a differential contribution to mortality by income group over time; high-income countries have been able to reduce the contribution from these risk factors in the last 20 years, whereas lower/middle income countries show an increasing trend in mortality attributable to high BMI and glucose. Although age-adjusted ACD mortality rate trends decreased globally, the absolute number of ACD deaths is increasing in part due to the growth of the population and aging, as well as to important lifestyle and food-system changes that likely attenuate gains in prevention. Population and individual level preventable causes of ACD must be aggressively and efficiently targeted in countries of lower economic development in order to reduce the growing burden of disease due to ACD. (C) 2015 IMSS. Published by Elsevier Inc.
引用
收藏
页码:328 / 338
页数:11
相关论文
共 50 条
  • [1] The global epidemic of atherosclerotic cardiovascular disease
    Yusuf, S
    Ounpuu, S
    Anand, S
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2002, 11 : 3 - 8
  • [2] Global Trends in Atherosclerotic Cardiovascular Disease
    Nedkoff, Lee
    Briffa, Tom
    Zemedikun, Dawit
    Herrington, Saranne
    Wright, F. Lucy
    [J]. CLINICAL THERAPEUTICS, 2023, 45 (11) : 1087 - 1091
  • [3] Cardiovascular Disease Epidemiology in Asia - An Overview -
    Ohira, Tetsuya
    Iso, Hiroyasu
    [J]. CIRCULATION JOURNAL, 2013, 77 (07) : 1646 - 1652
  • [4] The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes
    Pasquel, Francisco J.
    Gregg, Edward W.
    Ali, Mohammed K.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 1 - 32
  • [5] Epidemiology of cardiovascular disease in Japan: An overview study
    Ohira, Tetsuya
    Eguchi, Eri
    Hayashi, Fumikazu
    Kinuta, Minako
    Imano, Hironori
    [J]. JOURNAL OF CARDIOLOGY, 2024, 83 (03) : 191 - 200
  • [6] Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
    Bastien, Marjorie
    Poirier, Paul
    Lemieux, Isabelle
    Despres, Jean-Pierre
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2014, 56 (04) : 369 - 381
  • [7] Overview of hemostatic factors involved in atherosclerotic cardiovascular disease
    Kannel, WB
    [J]. LIPIDS, 2005, 40 (12) : 1215 - 1220
  • [8] Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
    Wu, Min
    Yu, Zongliang
    Li, Xiaoya
    Zhang, Xiaonan
    Wang, Songzi
    Yang, Shengjie
    Hu, Lanqing
    Liu, Longtao
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review
    Schoenfeld, Sara R.
    Kasturi, Shanthini
    Costenbader, Karen H.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 77 - 95
  • [10] Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
    Nissen, Steven E.
    Wolski, Kathy
    Cho, Leslie
    Nicholls, Stephen J.
    Kastelein, John
    Leitersdorf, Eran
    Landmesser, Ulf
    Blaha, Michael
    Lincoff, A. Michael
    Morishita, Ryuichi
    Tsimikas, Sotirios
    Liu, Junhao
    Manning, Brian
    Kozlovski, Plamen
    Lesogor, Anastasia
    Thuren, Tom
    Shibasaki, Taro
    Matei, Florin
    Silveira, Fabio Serra
    Meunch, Andreas
    Bada, Aysha
    Vijan, Vinod
    Bruun, Niels Eske
    Nordestgaard, Borge G.
    [J]. OPEN HEART, 2022, 9 (02):